RNS Number : 8815C
Marks & Spencer Group PLC
03 October 2018
 

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that it has been notified of the following transactions in the Company's Ordinary 25p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs').

The notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Rowe

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

Exercise of options from the 2015 Performance Share Plan (PSP) and 2015 Deferred Share Bonus Plan (DSBP) and sale of sufficient shares to cover the tax and NI liability, with the balance retained.

c)

Price(s) and volume(s)

Scheme

Price(s)

Volume(s)

2015 PSP

283.10p

21,387

2015 DSBP

283.10p

59,556

 

d)

Aggregated information

(Volume, price)

Acquired

Sold

Price

Retained

80,943

38,178

283.10p

42,765

 

e)

Date of the transaction

2018-10-02

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHXXLFBVBFZFBX